Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection.

Frontiers in immunology·2026
Same author

Temporal proteomic characterization of SARS-CoV-2 infected mouse lungs.

Molecular & cellular proteomics : MCP·2026
Same author

Multi-omics study to elucidate molecular mechanism of polyhexamethylene guanidine phosphate (PHMG-p)-induced pulmonary damage in mice.

Archives of toxicology·2026
Same author

Comprehensive proteogenomic characterization reveals clinically relevant molecular subtypes associated with medulloblastoma progression.

Experimental & molecular medicine·2026
Same author

cP1P Maintains Long-Term Pluripotency in Human Pluripotent Stem Cells.

International journal of stem cells·2026
Same author

Association between smoking cessation and depressive symptoms according to cessation duration, pack-years, and tobacco product type: a nationwide cross-sectional study in Korea.

Frontiers in public health·2026

相关实验视频

Updated: Jun 14, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

向GPX4棕化来增强抗瘤免疫力

Daehee Hwang1, Whitney S Henry1

  • 1Department of Biology, Massachusetts Institute of Technology, Koch Institute for Integrative Cancer Research, Cambridge, MA, USA.

Trends in cancer
|May 15, 2025
PubMed
概括

癌细胞通过抵抗细胞死亡过程铁亡来逃避免疫检测. 研究人员发现,抑制谷氨过氧化酶4 (GPX4) 棕化可以增强这种细胞死亡,改善免疫治疗结果.

科学领域:

  • 癌症研究 癌症研究
  • 免疫学 免疫学 免疫学
  • 细胞生物学 细胞生物学

背景情况:

  • 癌症免疫疗法已经进步,但瘤细胞经常逃避免疫监测.
  • 铁亡是一种受调节的细胞死亡形式,是癌症治疗的关键机制.
  • 谷氨过氧化酶4 (GPX4) 是铁亡的关键抑制剂.

研究的目的:

  • 调查GPX4修饰在铁灭症耐药性中的作用.
  • 探索针对GPX4进行癌症免疫治疗的潜力.

主要方法:

  • 这项研究的重点是GPX4与酶zDHHC8.8之间的相互作用.
  • 研究了GPX4棕化过程及其对铁亡的作用.

主要成果:

  • 周等人. 周等人. 已经证明zDHHC8调解GPX4.4的棕化.
  • 这种棕化增强了GPX4抑制铁亡的能力,使其对瘤细胞产生抵抗力.
  • 确定GPX4棕化是瘤细胞逃避免疫监测的机制.

结论:

  • 向GPX4棕化呈现了一种新的策略,以克服癌症中的铁死抵抗.
关键词:
在GPX4中使用GPX4.铁性化 (ferroptosis) 是一种免疫检查点封锁 (ICB)棕细胞代谢的发生瘤微环境 (TME) 是指瘤的微环境.zDHHC8 的时间.

更多相关视频

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.6K

相关实验视频

Last Updated: Jun 14, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.9K
Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
06:16

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity

Published on: December 7, 2019

12.6K
  • 通过抑制GPX4棕化来增强铁性,可以提高细胞毒性T细胞介导癌症免疫治疗的疗效.